
Print Options
PrintThe Whole
Instrument
PrintThe Whole
Schedule
PrintThe Whole
Part
PrintThis
Cross Heading
only
Changes over time for: Cross Heading: Decision of licensing authority


Timeline of Changes
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Status:
Point in time view as at 01/01/2022.
Changes to legislation:
The Human Medicines Regulations 2012, Cross Heading: Decision of licensing authority is up to date with all changes known to be in force on or before 02 May 2025. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations.

Changes to Legislation
Changes and effects yet to be applied by the editorial team are only applicable when viewing the latest version or prospective version of legislation. They are therefore not accessible when viewing legislation as at a specific point in time. To view the ‘Changes to Legislation’ information for this provision return to the latest version view using the options provided in the ‘What Version’ box above.
Decision of licensing authorityU.K.
10.—(1) After receiving the appropriate committee's report under paragraph 7 or 8 or notification under paragraph 9 the licensing authority must—U.K.
(a)decide whether to grant or renew the UK marketing authorisation, certificate of registration or traditional herbal registration;
(b)decide whether to grant or renew the authorisation, certificate or registration in accordance with the application; ...
(c)decide whether to proceed with its proposal to revoke, vary or suspend the authorisation, certificate or registration [; or
(d)decide whether to proceed with its proposal to decide that the orphan criteria are not met in relation to a medicinal product which is the subject of an application for the grant of a UK marketing authorisation,]
as the case may be.
(2) If the appropriate committee has given a report under paragraph 7 or 8, the licensing authority must take the report into account in making its decision.
(3) The licensing authority must notify the applicant or holder of—
(a)its decision; and
(b)any advice given to it by the appropriate committee and the reasons for that advice.
Back to top